Kohl N E, Diehl R E, Rands E, Davis L J, Hanobik M G, Wolanski B, Dixon R A
Department of Molecular Biology, Merck Sharp and Dohme Research Laboratories, West Point, Pennsylvania 19486.
J Virol. 1991 Jun;65(6):3007-14. doi: 10.1128/JVI.65.6.3007-3014.1991.
To generate nonpathogenic viral particles which express active human immunodeficiency virus type 1 (HIV-1) protease (PR), plasmids containing sequences from the genomes of HIV-1 and Moloney murine leukemia virus (M-MuLV) were constructed. Either the PR coding region alone; the gag, PR, and reverse transcriptase protein-coding regions; or the complete gag and pol protein-coding regions from HIV-1 were substituted for the corresponding regions of a full-length M-MuLV clone to yield the chimeric plasmids pMoHIV-I, pMoHIV-III, and pMoHIV-IV, respectively. Cell lines which express the viral gag polyprotein were isolated for hybrids pMoHIV-I and pMoHIV-III. These cells produced viral particles which contained processed core proteins. Cleavage of the gag polyprotein in the viral particles was inhibited by the HIV-1 PR inhibitor L-687908, indicating that the viral PR is responsible for the observed processing. The hybrid virions were not infectious; analyses indicated that the viral particles contained little or no reverse transcriptase activity. In addition, particles produced by pMoHIV-III transfectants failed to package the viral genomic RNA. The cell line which expresses and processes the HIV-1 gag polyprotein is a safe and effective reagent for the in vivo evaluation of potential inhibitors of the HIV-1 PR.
为了产生表达活性人类免疫缺陷病毒1型(HIV-1)蛋白酶(PR)的非致病性病毒颗粒,构建了含有HIV-1和莫洛尼鼠白血病病毒(M-MuLV)基因组序列的质粒。单独的PR编码区;gag、PR和逆转录酶蛋白编码区;或HIV-1的完整gag和pol蛋白编码区分别替代全长M-MuLV克隆的相应区域,以分别产生嵌合质粒pMoHIV-I、pMoHIV-III和pMoHIV-IV。分离出表达病毒gag多聚蛋白的细胞系用于pMoHIV-I和pMoHIV-III杂交体。这些细胞产生了含有加工后核心蛋白的病毒颗粒。HIV-1 PR抑制剂L-687908抑制了病毒颗粒中gag多聚蛋白的切割,表明病毒PR负责观察到的加工过程。杂交病毒粒子没有感染性;分析表明病毒颗粒几乎没有或没有逆转录酶活性。此外,pMoHIV-III转染细胞产生的颗粒未能包装病毒基因组RNA。表达和加工HIV-1 gag多聚蛋白的细胞系是用于体内评估HIV-1 PR潜在抑制剂的安全有效试剂。